Loading...
Multiple clinical trials support using statins for primary prevention of atherosclerotic cardiovascular disease (ASCVD) events. Professional organizations' guidelines vary in their recommendations about who is eligible to receive statins. Investigators used a Danish population database (>45,000 people; age range, 40–75) to compare estimated number of ASCVD events (i.e., myocardial infarction, stroke, or cardiac-related death) that would be prevented, based on patient eligibility as recommended by five published guidelines: American College of Cardiology/American Heart Association (ACC/AHA), U.K. National Institute for Health and Care Excellence (NICE), Canadian Cardiovascular Society (CCS), U.S. Preventive Services Task Force (USPSTF), and …